Introduction
It has been widely reported that mechanical ventilation increases the risk of nosocomial pneumonia by a factor of 6 to 21 [1] [2] [3] [4] [5] . Endotracheal intubation can facilitate the movement of organisms from the oropharynx into the trachea. Leakage around the cuff of the Endotracheal (ET) Tube allows pooled secretions above the cuff to enter the trachea and bronchi 6 . Bacteria amass on the surface of the ET tube, become irreversibly attached, producing extracellular polysaccharides and form a biofilm, where the sessile organisms are protected from host defences [7] [8] [9] . Assisted by ventilator flow or by suctioning, biofilm encased bacteria may become dislodged and travel into the lower airways 10 , resulting in ventilator associated pneumonia and the attendant associated considerable morbidity, mortality and increased hospital care costs 11 .
To optimise the performance of the ET tube, methods that can reduce or eliminate bacterial colonisation and/or augment the efficacy of antibiotics delivered locally or systemically should be pursued 5, 12 . Technologies under consideration include subglottic secretion pooling (both above 13 and below the cuff 14 ), cuff design and operation and the use of antimicrobial-coated ET tubes 5 . The role of antimicrobial coatings to affect the resistance of the ET tube to biofilm formation (and hence ventilator associated pneumonia) has been examined in a number of studies. For example, Berra et al.. compared the clinical ability of silver sulfadiazine coated and noncoated (control) ET tubes to prevent bacterial colonisation and concluded that the antibiotic-coating prevented bacterial colonisation of the endotracheal tube for up to 24h intubation 15 . Similarly, the ability of a silver-coated ET tube to delay the rate and extent of bacterial colonisation and bacterial bioburden has been reported 16 whereas the ability of a silver sulphadiazine/chlorhexidine coating to eliminate/reduce bacterial colonisation in a sheep model has been described 17 . Contrary to these reports, in a clinical study, Kaflon et al. 18 reported that silver-impregnated multi-lumen catheters were not associated with a lower colonisation rate than their non-silver impregnated counterparts when evaluated in a clinical scenario whereas Desai et al. . concluded that impregnation of catheters with silver or nitrofurazone did not significantly affect bacterial adherence in comparison to control catheters 19 . Whilst the evidence generally confirms the affirmative role of local antimicrobial delivery, it is appreciated that the delivery of the antimicrobial agent from such coatings is not fully understood nor optimised, particularly within the respiratory environment in which the volume of fluid for drug elution is limited.
In an innovative strategy, the authors (Adair et al..) described the use of nebulised gentamicin for the prevention of bacterial biofilm on ET tubes and hence ventilator associated pneumonia 10 .
In a clinical study the authors reported that high concentrations of gentamicin were attained within the lumen of the ET tube following nebulisation resulting in an improved strategy for the prevention of ET tube biofilm when compared with parenterally administered cefoxatime. Accordingly, this study proved that if sufficient concentrations of antimicrobial agent are obtained within the lumen of the ET tube ventilator-associated pneumonia might be prevented. One of the limitations of this approach is the need for frequent nebulisation due to the negligible retention of the nebulised antibiotic at the luminal surface of the ET tube. Whilst it has been reported that there is minimal systemic absorption of gentamicin and good tolerance within the airways when administered by nebulisation 20, 21 , it is clinically preferable to minimise the exposure of patients to antimicrobial agents to abate the development of multidrug resistant pathogens [22] [23] [24] .
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To address these concerns this study describes a pharmaceutical strategy in which candidate hydrogels are used as luminal coatings of ET tubes to specifically entrap nebulised antimicrobial solutions (gentamicin in this study). These coatings will therefore act as a platform for the subsequent delivery of gentamicin to bacteria adherent on the surface of the ET tube and hence reduce the frequency of nebulisation.
This approach obviates the need to preload the ET tube with antimicrobial agent and allows the clinician to accurately control the usage of antimicrobial agent, thereby minimising the emergence of microbial resistance. This is the first report of the use of capture coatings for nebulised antimicrobial solutions and offers an exciting pharmaceutical strategy to reduce/prevent nosocomial pneumonia in the intensive care unit. All other chemicals were obtained from Sigma-Aldrich Co Ltd (Dorset England).
Materials and Methods

Materials
2,2'-Azo-bis(2-methylpropionitrile) (AIBN) was purchased from BDH Laboratory
Bacterial isolates
The clinical isolates used in this study, namely Staphylococcus aureus and Pseudomonas aeruginosa, originated from microbial biofilm present on the surface of retrieved PVC endotracheal tubes from the intensive care unit of The Royal Victoria Hospital, Belfast. The organisms were maintained on beads (Protect Bacterial Preserve System, Technical Services Consultants Ltd., UK) and on agar in 10% glycerol at -70°C. Subculturing was performed at three monthly intervals, on MHA slopes stored at 4°C.
Preparation of hydrogels and hydrogel-coated poly(vinyl chloride)
A series of hydrogels were prepared by free radical polymerisation of 2hydroxyethylmethacrylate and methacrylic acid (10, 20, 30 % w/w) using 1.0% w/w 2,2'-Azo-bis(2-methylpropionitrile) (AIBN) as an initiator, and cross-linked using 0.5% w/w ethylene glycol dimethacrylate, as previously described by the authors 25, 26 . The monomer systems (including cross-linker and initiator) were injected into a mould compromising two glass sheets (150 x 100mm), which contained a loop of silicone tubing between a sheet of silicone coated release liner, and clamped together with bulldog clips to avoid leakage. The mould was then placed in a vacuum oven at 60°C for 18 hours, following which, the polymer was removed and washed in deionised water for 14 days to remove any unreacted monomers. All hydrogels were then stored in deionised water until required for analysis.
Poly(vinyl chloride, PVC) was prepared using emulsion polymerisation, as previously reported by the authors 27 . When required, coating of the hydrogels onto PVC was performed using a modification to the method described by McGinty and Brittain 28 . In this a section of PVC film (3cm x 3cm x 200µm) was immersed in a solution of monomer (HEMA, or various ratios of HEMA:MAA) containing 2,2'-azobisisobutyronitrile and ethylene glycol dimethacrylate, as described above. The mixture was covered and heated to 60°C in a thermostatically controlled oven until the acrylate layer became viscous. The sample was then removed and pressed between two glass plates before being returned to the oven at 60°C for 18 hours. Samples were removed and soaked in deionised water for 24 hours to remove remaining unpolymerized monomer.
Analysis of gentamicin using high performance liquid chromatography
Due to the lack of a suitable chromophore, pre-column derivatisation of gentamicin was performed by reaction with excess 2,4-dinitrofluorobenzene. In this gentamicin was Components were detected at 365 nm and external standardisation was used. The mobile phase was filtered and degassed on a 0.45 μm membrane (Millipore, Bedford, MA, USA) before use. The chromatographs obtained were analysed using Shimadzu Class VP® software. The relationship between peak area and concentration was linear (r> 0.99) over a concentration range of 5-250 μg mL -1 .
Preparation of gentamicin loaded hydrogels
Copolymers with a range of HEMA: MAA mass ratios (100:0, 90:10, 80:20, 70:30) were loaded with drug by immersion in a buffered gentamicin solution (isotonic Tris, pH 7.4, 50 mg mL -1 gentamicin sulfate) and placement in a shaking water bath (100 oscillations min -1 ) at 37°C. Prior to immersion each section of p(HEMA) and p(HEMA-co-MAA) was dried in an oven. After immersion and prior to subsequent analysis of the materials, surface gentamicin solution was removed by placing the sample in a meshed metal basket and rinsing three times in isotonic Tris buffer, each for five seconds. The sample was then gently blotted dry between two pieces of filter paper. To quantify the mass of incorporated gentamicin, the drug was extracted five times into pre-heated buffered solution (isotonic Tris pH 7.4) under shaking water conditions (100 oscillations min -1 ) at 37°C. The mass of gentamicin in the various extracts was quantified using HPLC, as described above. To ensure all gentamicin was extracted, at the end of the analysis the samples were ground up in mortar and pestle, placed in fresh Tris buffer and the mass of drug quantified. All analyses were repeated at least five times.
Buffer uptake of p(HEMA) and p(HEMA-co-MAA) hydrogels
Samples of hydrated p(HEMA) and p(HEMA-co-MAA) were prepared and dried in an oven until a steady state weight was achieved. The discs were then accurately weighed, transferred to stoppered vials containing Tris buffer (pH 7.4, isotonic) and incubated under shaking conditions at 37ºC. At pre-selected times each sample was removed, blotted dry between 2 pieces of filter paper and then reweighed before being returned to the stoppered vial containing Tris buffer (pH 7.4) until the next time period. The buffer uptake was defined as the swelling ratio (SR) using the following equation. At least five replicate analyses were performed.
Where:
W w is the wet weight of the sample W d is the dry weight of the sample
Determination of hydrogel network parameters
From the swelling data the following network parameters were calculated 29 :
The molecular weight of the polymer chain between two neighbouring cross-
d p is the density of the polymer (g cm -1 ) V s is the molar volume of the solvent (18 cm 3 mol -1 )
Χ is the Flory-Huggins interaction parameter
ϕ is the volume fraction of the polymer in the swollen state, calculated using:
Where, in addition to the above: d s is the density of the solvent (g cm -3 ) W ∞ is the weight of the hydrogel at equilibrium W o is the dry polymer weight
Mean pore size (nm) of the polymeric network of the hydrogel (ζ)
Tensile analysis
The mechanical properties of the various equilibrium-hydrated hydrogels were determined using a Stable Micro Systems TA-XT2 Texture Analyser, as previously reported by the authors 25 Young's Modulus and % elongation at break were calculated.
Modulated temperature differential scanning calorimetry (MTDSC)
The glass transition temperatures of dried p(HEMA) and p(HEMA-co-MAA) hydrogels were analysed using a DSC 2920 Modulated DSC (TA Instruments, Leatherhead, UK) in modulated temperature mode with an attached refrigerated cooling system (RCS) unit.
Calibration of the instrument was conducted using the melting of indium, cyclohexane and tin standards. Nitrogen was used as the purge gas, flowing at a rate of 30mL min -1 through the DSC cell and at 150 mL min -1 through the RCS unit. The mass of each empty sample pan matched the mass of the empty reference pan to ± 0.1mg. TA Instruments aluminium pinhole hermetic pans were used throughout the experiments.
Each analysis consisted of an initial two minute isothermal period at 25 °C followed by a modulation amplitude of ± 0.21°C every 40 seconds with a 2°C min -1 underlying heating rate to 200°C. Experiments were repeated at least 5 times for each candidate hydrogel.
Modelling of the data was performed using the Gordon-Taylor equation 31 .
Gentamicin release
The 32, 33 . The mass of gentamicin released was then quantified by HPLC as described above.
Bacterial adherence to p(HEMA) and p(HEMA-co-MAA) hydrogels both containing and devoid of with gentamicin
Adherence of stationary phase bacteria to p(HEMA) and p(HEMA-co-MAA) hydrogels (either devoid of or containing gentamicin as defined in section 2.5) was examined using a modification of a method previously reported by the authors 27, 34 . In this, a volume (20 mL, circa 1 x10 8 colony forming units mL -1 ) of the bacterial suspension was added to McCartney bottles, each of which contained three hydrogel discs placed on a needle. The bottles were incubated in an orbital incubator (37°C, 100 oscillations min -1 )
for periods of 1, 4 and 24 hours. Upon removal at the pre-selected times, the needles with attached samples were washed gently three times with 20 mL sterile peptone water to remove any non-adherent bacteria. Adherent bacteria were removed by placing the individual hydrogel discs in 10 mL volumes of peptone water, sonicating in an ultrasonic bath for 5 minutes and vortexing for 30 seconds. The number of adherent bacteria to each biomaterial was then determined by serial dilution.
Bacterial viability on p(HEMA) and p(HEMA-co-MAA) hydrogels following exposure to nebulised gentamicin
In this method, samples of PVC with an attached hydrogel coating were prepared (surface area 25 cm 2 ), fixed in position using a clamp and exposed to gentamicin via nebulisation (4 mL, 80 mg for 20 minutes) or to isotonic Tris buffer (pH 7.4, as a control). The distance between the nebuliser and the material was maintained at 5 cm.
The dose and duration of nebulisation was selected on the basis of a previous report 10 .
A suspension of bacteria (4 mL circa 1 x 10 9 colony forming units mL -1 ) was then aseptically transferred into the Hudson Micro Mist® small volume nebulising chamber which was attached to the small volume nebuliser (DeVilbiss SunMist Plus®). The nebuliser was aimed at the hydrogel coatings and was permitted to run for a period of thirty minutes after which time samples of each material were removed from the material and viable bacterial adherence calculated as described above.
Examination of antimicrobial persistence
A volume (0.5 mL) of stationary phase S. aureus or Ps. aeruginosa (circa 2 x10 7 colony forming units mL -1 ) was added to a sterile Petri dish and molten agar (20mL Mueller
Hinton Agar) added. The dish was swirled to adequately mix the agar and then allowed to solidify. A gentamicin containing hydrogel sample (prepared as described in the materials and methods) was placed onto the agar surface using sterile forceps and the dish incubated at 37°C for 18 hours. After this period the zones of complete inhibition were measured (n ≥ 5 in each case). To investigate the persistence of activity of these materials the sample discs were removed from the agar plates after the first 18 hours of incubation and transferred, using sterile forceps, to a freshly seeded plate (S. aureus and Ps. aeruginosa respectively) and incubated for a further 18 hours. The persistence of activity was determined by transferring the samples to fresh seeded plates after each incubation period until no further zones were produced.
Statistical analysis
All experiments were performed at least five times and the results expressed as the mean ± standard deviation. The effect of hydrogel composition on the mechanical properties, swelling properties, network parameters, drug loading and bacterial adherence (at each sampling point) were statistically evaluated using a one-way Analysis of Variance (ANOVA). The effects of hydrogel composition on gentamicin release and on the persistence of antimicrobial activity in the zone of inhibition assay were statistically evaluated using a repeated measures one-way ANOVA. Individual differences between the various materials in the above analyses were statistically identified using Tukey's HSD test. Linear regression analysis was performed when required and the significance of this assessed using the one-way ANOVA in association with examination of residuals. In all cases a probability of p < 0.05 was selected to denote significance.
Results and Discussion
The use of aerosolised antibiotics has been reported to be a successful strategy to prevent/reduce the incidence of ventilator-associated pneumonia. For example, Adair et al. 10 
Attachment of Hydrogels to PVC
To perform as an effective coating, it is essential to ensure that the coating remains Attachment of the coating to the substrate was robust and homogeneous following equilibrium swelling.
Physicochemical Properties of Hydrogels
The 
Hydrogel Swelling Studies and Network Parameters
The buffer uptake properties of p(HEMA) and p(HEMA-co-MAA) are displayed in Figure   1 . As may be observed the relationship between swelling ratio and time was non-linear for each material. The greatest swelling ratio (at equilibrium uptake) was exhibited by the copolymer composed of p(HEMA-co-MAA, 70:30) (3.56 ± 0.34) whereas the lowest swelling ratio was associated with p(HEMA) homopolymer (0.57 ± 0.01). The other materials exhibited swelling ratios that were significantly different from one another and lay between these values. Modelling of the swelling properties was performed using a power law model to provide information on the mechanism of swelling, defined using the exponent (n) ( Table 2) 37, 41 . From this it was observed that the exponent significantly increased as the mass of MAA was increased within the biomaterials.
Hence the greatest exponent was displayed by p(HEMA-co-MAA, 70:30) whereas the lowest value of this parameter was associated with p(HEMA). The ability of copolymers of HEMA:MAA to exhibit greater swelling than p(HEMA) is accredited to the ability of the hydrogels to ionise and undergo charge-mediated, polymer chain repulsion 42 .
Consideration of the swelling exponents confirmed that the mechanism of buffer uptake by p(HEMA) and the various copolymers was anomalous and is in accordance with a combination of factors, including the rate of ionisation at the glassy/rubbery interface 37 .
The uptake of gentamicin was directly related to the swelling properties; with materials exhibiting increased swelling showing the greatest mass of absorbed gentamicin (Table   2 ). Accordingly, decreasing the ratio of HEMA to MAA in the hydrogels significantly increased the loading of gentamicin, reaching a maximum at a hydrogel ratio of 70:30.
The network parameters associated with the various hydrogels, calculated using swelling data 29 , are presented in Table 2 . As the ratio of HEMA:MAA within the hydrogels was decreased sequentially from 100:0 to 70:30 the molecular weight of the polymer chain between two neighbouring cross links and the mesh size increased whereas the cross link density and the volume fraction of the polymer in the swollen state decreased. Accordingly, as the mass of MAA within the hydrogels increased (and at physiological pH under which conditions there is >99% ionisation of the carboxylic acid groups), the increased mesh size facilitated fluid absorption. The uptake of gentamicin into the fluid filled regions between the polymer chains was dependent on the mesh size. Assuming the hydrodynamic radius of gentamicin is similar to that of other small organic drug molecules 43 , the lower mesh size of p(HEMA) (1.81±0.00nm) will act to preclude drug uptake within the mesh volume. As the mesh size increases the uptake of gentamicin increases thereby facilitating gentamicin uptake. The uptake of gentamicin into the hydrogel composed of 70:30 HEMA:MAA (mesh size 39.18±1.83nm) was greater than into the hydrogel composed of 80:20 HEMA:MAA hydrogel (mesh size 33.64±1.59nm) however the extent of the uptake of gentamicin into the 90:10 HEMA:MAA hydrogel (mesh size 24.43±1.02nm) was markedly less.
Accordingly a mesh size of >30nm facilitates substantial loading of this hydrogel with gentamicin.
Gentamicin Release from Hydrogels
The composition of the hydrogels significantly affected the subsequent mass of gentamicin released as a function of time (Figure 2a ). The release of gentamicin from p(HEMA) was rapid and uncontrolled (with low released mass) due to the low drug loading (and surface location) of gentamicin (data not shown). Consequently 100% drug release had occurred by the first sampling period (15mins). The overall mass of drug released was dependent on the initial drug loading (table 2) , which was, in turn, significantly affected by the composition of the hydrogel. Figure 2b represents the data as the fractional drug release to facilitate comparison of the release rates of the gentamicin from the three hydrogels. As may be observed, the release of gentamicin was relatively rapid from the hydrogel co-polymers, with 50% release occurring within the first 15 minutes. The release rates of gentamicin from the hydrogels composed of Based on these observations, the p(HEMA) hydrogel did not offer suitable properties (drug uptake and release) to be considered as a suitable as a gentamicin capture coating designed for the prevention of ventilator-associated pneumonia. However, the properties of the other co-polymers showed promise in this regard.
Antimicrobial and Microbial Anti-Adherence Properties of Hydrogels
The National Nosocomial Infection Surveillance (NNIS) system reported that mechanical ventilation was implicated in 83% of episodes of nosocomial pneumonia, with endotracheal intubation cited as an obvious predisposing factor for ventilatorassociated pneumonia 47 . S. aureus and Ps. aeruginosa have emerged as the principal causative organisms of ventilator-associated pneumonia 48, 49 . Therefore clinical isolates of these pathogens were selected to evaluate the antimicrobial properties of the candidate hydrogels. These properties of the hydrogels were assessed in terms of their resistance to microbial adherence and the persistence of antimicrobial activity, the latter assessed using a seed plate method. Microbial adherence to biomaterials is accepted to represent the initial stage of medical device colonisation 38, 50, 51 To simulate the performance of these hydrogel systems under clinical conditions, this study examined the ability of the coatings that had been pre-treated by nebulisation with a solution of gentamicin (using a clinical nebuliser) or Tris buffer (as a control) and then exposed to nebulised bacteria, to resist microbial colonisation on the surface of the coating. Microbial survival on exemplar hydrogels either containing or devoid of (nebulised) gentamicin is shown in Table 5 . Following nebulisation of both microorganisms on each control (non-gentamicin treated) material microbial colonisation resulted, the extent of which was dependent on the composition of the hydrogel. Importantly, microbial colonisation on the p(HEMA: MAA) copolymers that had previously been exposed to gentamicin via nebulisation was not observed.
Conversely, microbial adherence was observed on p(HEMA) that had previously been exposed to gentamicin however, the extent of this was dramatically lower than to control (non-treated) p(HEMA). In this experimental method, gentamicin was not released into a bathing solution and therefore the concentration and availability of gentamicin relates to the concentration of this antimicrobial agent within the aqueous filled pores of the polymer matrix. Upon contact with the hydrogel, the bacteria will be in direct contact with this gentamicin-containing aqueous interface and therefore gentamicin will be directly available to exert its antimicrobial effect. Furthermore, it should be noted that the available gentamicin concentration will far exceed that which may be obtained following administration of this drug by other means 10 . The activity of p(HEMA) was inferior to the hydrogel copolymers and may be accredited to the lower uptake of gentamicin within the matrix of this polymer following nebulisation and hence the lower availability of antimicrobial agent.
Conclusions
This study uniquely describes a novel pharmaceutical strategy for the prevention of 
